Skip to content
healthcare.dev
Get a free key

Neostigmine Methylsulfate

NDC 76045-383, Neostigmine Methylsulfate, injection, solution, from Fresenius Kabi USA, LLC.

Product NDC
76045-383
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA203629
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76045-383 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEOSTIGMINE METHYLSULFATE1 mg/mL

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
76045-383-307604503833010 BLISTER PACK in 1 CARTON (76045-383-30) / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-383-13) / 3 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b0b509c3-8dc8-48cc-b7a8-16b93ad706c6

Use it

Look up 76045-383 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76045-383 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76045-383. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.